Schedule 13D ownership disclosure
VYNE THERAPEUTICS INC
Security class unavailable · CUSIP: 92941V100
Event date: 2023-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-275417
- Form type
- SC 13D
- Filer
- AI Biotechnology LLC
- CIK
- CIK 1942670
- Filed
- Nov 13, 2023
- Reporting period
- Nov 01, 2023
- Description
- Schedule 13D beneficial ownership